login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
ARGENX SE - ADR (ARGX) Stock News
USA
-
Nasdaq
- NASDAQ:ARGX -
US04016X1019
-
ADR
906.74
USD
-12.18 (-1.33%)
Last: 11/24/2025, 8:00:00 PM
906.74
USD
0 (0%)
After Hours:
11/24/2025, 8:00:00 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
ARGX Latest News, Press Relases and Analysis
All
Press Releases
11 days ago - By: Chartmill
Argenx SE - ADR (NASDAQ:ARGX) Fits Navellier's 'Little Book' Growth Rules
6 days ago - By: Benzinga
- Mentions:
ARWR
HSIC
HUM
LLY
...
10 Health Care Stocks With Whale Alerts In Today's Session
6 days ago - By: Benzinga
$1000 Invested In argenx 5 Years Ago Would Be Worth This Much Today
6 days ago - By: argenx SE
argenx Announces Results of Extraordinary General Meeting of Shareholders
6 days ago - By: argenx SE
argenx Announces Results of Extraordinary General Meeting of Shareholders
15 days ago - By: Zacks Investment Research
- Mentions:
KROS
KROS vs. ARGX: Which Stock Is the Better Value Option?
21 days ago - By: Zacks Investment Research
- Mentions:
JNJ
HALO
Halozyme Beats on Q3 Earnings & Revenues, Raises 2025 View
26 days ago - By: Investor's Business Daily
- Mentions:
INSM
UTHR
LQDA
Insmed Catapults While IBD 50's Argenx Creeps Higher On Bullish Reports
a month ago - By: argenx SE
argenx Reports Third Quarter 2025 Financial Results and Provides Business Update
a month ago - By: argenx SE
argenx Reports Third Quarter 2025 Financial Results and Provides Business Update
a month ago - By: argenx SE
argenx Presents New Data at AANEM and MGFA Highlighting the Strength and Broad Benefit of VYVGART for Myasthenia Gravis Patients
a month ago - By: argenx SE
argenx Presents New Data at AANEM and MGFA Highlighting the Strength and Broad Benefit of VYVGART for Myasthenia Gravis Patients
a month ago - By: argenx SE
argenx to Report Third Quarter 2025 Financial Results and Business Update on October 30, 2025
a month ago - By: argenx SE
argenx to Report Third Quarter 2025 Financial Results and Business Update on October 30, 2025
a month ago - By: The Motley Fool
- Mentions:
TTD
AMZN
PEP
CELH
...
Checking In on The Trade Desk, Bristol Myers Squibb, and Other Stocks
a month ago - By: argenx SE
argenx to Highlight Key Data and Breadth of Immunology Innovation at 2025 AANEM Annual Meeting and MGFA Scientific Session
a month ago - By: argenx SE
argenx to Highlight Key Data and Breadth of Immunology Innovation at 2025 AANEM Annual Meeting and MGFA Scientific Session
2 months ago - By: argenx SE
argenx announces Extraordinary General Meeting of Shareholders on November 18, 2025
2 months ago - By: argenx SE
argenx announces Extraordinary General Meeting of Shareholders on November 18, 2025
2 months ago - By: Zacks Investment Research
- Mentions:
INCY
INCY vs. ARGX: Which Stock Is the Better Value Option?
2 months ago - By: Zacks Investment Research
- Mentions:
HALO
ABBV
ANIP
AbbVie Seeks FDA Nod for Tavapadon to Treat Parkinson's Disease
2 months ago - By: Investor's Business Daily
- Mentions:
XPH
PPH
XBI
IBB
...
Pharma Tariffs Back In Spotlight On New Trump Threat
3 months ago - By: Investor's Business Daily
- Mentions:
UTHR
AUPH
HALO
United Therapeutics Price Strength Rating Jumps After Its Stock Soared 33% Last Week On Positive Drug Test Results
3 months ago - By: Investor's Business Daily
- Mentions:
DNTH
AZN
SNY
Why Dianthus Therapeutics, Up 47% In Four Weeks, Just Surged Again
Please enable JavaScript to continue using this application.